Company Overview of Numira Biosciences, Inc.
Numira Biosciences, Inc., a contract research organization, provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. It offers Virtual Histology for soft tissue imaging applications, such as atherosclerosis, osteoarthritis, heart defects, pulmonary diseases, developmental biology, and phenotyping; and high-resolution bone imaging tools to analyze and characterize the skeletal anatomy and bones of animal models. The company also provides image processing and visual analytics solutions; AltaViewer visualization software, a visualization tool for use in non-clinical environments to view, manipulate, and export images of small animal datasets for...
2151 Michelson Drive
Irvine, CA 92612
Founded in 2005
Key Executives for Numira Biosciences, Inc.
President and Chief Operating Officer
Vice President of Sales and Marketing
Compensation as of Fiscal Year 2014.
Numira Biosciences, Inc. Key Developments
Numira Appoints Kim Killian as Regional Sales Manager of the Southwestern Region
Apr 8 14
Numira announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. Kim will work to extend support services to the rapidly expanding sectors in Southern California, Arizona, Nevada, and Utah.
Numira Appoints David Raminick as Vice President of Sales and Marketing
Apr 1 14
Numira announced the appointment of David Raminick as Vice President of Sales and Marketing. Prior to joining Numira, Raminick served as VP of Business Development and Strategy for Radiate Media. Additionally, he held key management roles for Audi, Volkswagen Credit/Audi Financial Services and the Volkswagen brand.
Numira Appoints Hal Widlansky as CEO
Jan 21 14
Numira has appointed Hal Widlansky as CEO. Prior to taking the helm at Numira, Widlansky served as President and COO of Radiate Media.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries